UK Markets closed

NantHealth, Inc. (NH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.4264+0.0088 (+2.11%)
At close: 04:00PM EDT
0.4400 +0.01 (+3.19%)
After hours: 06:29PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.76
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 32.5100
52-week low 30.4030
50-day moving average 30.5884
200-day moving average 31.0038

Share statistics

Avg vol (3-month) 3137.04k
Avg vol (10-day) 3397.79k
Shares outstanding 5115.44M
Implied shares outstanding 6N/A
Float 830.15M
% held by insiders 158.45%
% held by institutions 120.74%
Shares short (28 Apr 2022) 4973.85k
Short ratio (28 Apr 2022) 410.81
Short % of float (28 Apr 2022) 43.23%
Short % of shares outstanding (28 Apr 2022) 40.84%
Shares short (prior month 30 Mar 2022) 4853.35k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021


Profit margin -92.99%
Operating margin (ttm)-65.28%

Management effectiveness

Return on assets (ttm)-12.84%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)62.65M
Revenue per share (ttm)0.55
Quarterly revenue growth (yoy)-14.00%
Gross profit (ttm)39.83M
EBITDA -35.05M
Net income avi to common (ttm)-58.28M
Diluted EPS (ttm)-0.5490
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)29.08M
Total cash per share (mrq)0.25
Total debt (mrq)258.48M
Total debt/equity (mrq)N/A
Current ratio (mrq)1.41
Book value per share (mrq)-1.27

Cash flow statement

Operating cash flow (ttm)-27.69M
Levered free cash flow (ttm)-19.33M